Shuichi Tawara

1.4k total citations
34 papers, 1.0k citations indexed

About

Shuichi Tawara is a scholar working on Pharmacology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Shuichi Tawara has authored 34 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 14 papers in Infectious Diseases and 11 papers in Molecular Medicine. Recurrent topics in Shuichi Tawara's work include Antibiotics Pharmacokinetics and Efficacy (14 papers), Antibiotic Resistance in Bacteria (11 papers) and Antifungal resistance and susceptibility (8 papers). Shuichi Tawara is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (14 papers), Antibiotic Resistance in Bacteria (11 papers) and Antifungal resistance and susceptibility (8 papers). Shuichi Tawara collaborates with scholars based in Japan, New Zealand and Germany. Shuichi Tawara's co-authors include Shōgo Kuwahara, Fumiaki Ikeda, Satoru Matsumoto, Toshio Goto, Fumio Matsumoto, Katsuyuki Maki, Yoshimi Matsumoto, Toru Nakai, Yoshimi Wakai and Hisashi Takasugi and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Antimicrobial Agents and Chemotherapy and Bioorganic & Medicinal Chemistry.

In The Last Decade

Shuichi Tawara

34 papers receiving 970 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuichi Tawara Japan 16 598 449 301 183 132 34 1.0k
Domingo Gargallo‐Viola Spain 20 503 0.8× 372 0.8× 185 0.6× 261 1.4× 24 0.2× 42 1.3k
Andrew T. Nishimoto United States 15 878 1.5× 623 1.4× 142 0.5× 256 1.4× 45 0.3× 20 1.4k
Robert S. Gordee United States 15 387 0.6× 257 0.6× 191 0.6× 305 1.7× 58 0.4× 30 869
Anna Karawajczyk Netherlands 15 828 1.4× 518 1.2× 234 0.8× 530 2.9× 134 1.0× 21 1.5k
Haruaki Tomioka Japan 22 585 1.0× 594 1.3× 96 0.3× 359 2.0× 64 0.5× 90 1.3k
Charles Gill United States 13 267 0.4× 189 0.4× 237 0.8× 328 1.8× 37 0.3× 22 747
Keith Barrett‐Bee United Kingdom 16 530 0.9× 312 0.7× 121 0.4× 408 2.2× 31 0.2× 34 1.1k
Santiago Ramón‐García Spain 16 564 0.9× 451 1.0× 118 0.4× 393 2.1× 65 0.5× 31 1.0k
Richard Hector United States 9 555 0.9× 532 1.2× 121 0.4× 231 1.3× 115 0.9× 15 1.1k
Khye Seng Goh Guadeloupe 27 1.2k 1.9× 1.3k 3.0× 158 0.5× 436 2.4× 236 1.8× 52 1.7k

Countries citing papers authored by Shuichi Tawara

Since Specialization
Citations

This map shows the geographic impact of Shuichi Tawara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuichi Tawara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuichi Tawara more than expected).

Fields of papers citing papers by Shuichi Tawara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuichi Tawara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuichi Tawara. The network helps show where Shuichi Tawara may publish in the future.

Co-authorship network of co-authors of Shuichi Tawara

This figure shows the co-authorship network connecting the top 25 collaborators of Shuichi Tawara. A scholar is included among the top collaborators of Shuichi Tawara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuichi Tawara. Shuichi Tawara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamauchi, Tomohiro, Naoto Nakamura, Masashi Hiramoto, et al.. (2012). Sepantronium Bromide (YM155) induces disruption of the ILF3/p54nrb complex, which is required for survivin expression. Biochemical and Biophysical Research Communications. 425(4). 711–716. 62 indexed citations
2.
Maki, Katsuyuki, Satoru Matsumoto, Masaki Tomishima, et al.. (2008). Use of a serum‐based antifungal susceptibility assay to predict the in vivo efficacy of novel echinocandin compounds. Microbiology and Immunology. 52(8). 383–391. 17 indexed citations
3.
Maki, Katsuyuki, Masaki Tomishima, Hidenori Ohki, et al.. (2006). Determination of Antifungal Activities in Serum Samples from Mice Treated with Different Antifungal Drugs Allows Detection of an Active Metabolite of Itraconazole. Microbiology and Immunology. 50(4). 281–292. 3 indexed citations
4.
Yamamoto, Hirofumi, Shinya Okuda, Kohji Kawabata, et al.. (2002). Orally Active Cephalosporins. Part 4: Synthesis, Structure–Activity Relationships and Oral Absorption of Novel 3-(4-Pyrazolylmethylthio)cephalosporins with Various C-7 Side Chains. Bioorganic & Medicinal Chemistry. 10(5). 1535–1545. 9 indexed citations
5.
Yamamoto, Hirofumi, Ayako Nakamura, Kohji Kawabata, et al.. (2001). Orally active cephalosporins. Part 3: synthesis, structure–activity relationships and oral absorption of novel C-3 heteroarylmethylthio cephalosporins. Bioorganic & Medicinal Chemistry. 9(2). 465–475. 11 indexed citations
6.
Matsuda, Keiji, Hiroshi Sasaki, Yoshimi Matsumoto, et al.. (2000). studies on anti-helicobacter pylori agents. part 2: new cephem derivatives. Bioorganic & Medicinal Chemistry. 8(9). 2317–2335. 8 indexed citations
7.
Matsumoto, Satoru, Yoshimi Wakai, Toru Nakai, et al.. (2000). Efficacy of FK463, a New Lipopeptide Antifungal Agent, in Mouse Models of Pulmonary Aspergillosis. Antimicrobial Agents and Chemotherapy. 44(3). 619–621. 77 indexed citations
8.
Yamamoto, Hirofumi, A. Ohki, Fumiyuki Shirai, et al.. (2000). Orally active cephalosporins: synthesis, structure–activity relationships and oral absorption of 3-[(E) and (Z)-2-Substituted vinyl]-cephalosporins. Bioorganic & Medicinal Chemistry. 8(1). 43–54. 8 indexed citations
9.
Watanabe, Yuji, Kazuo Hatano, Yoshimi Matsumoto, et al.. (1999). In Vitro Antibacterial Activity of FK041, a New Orally Active Cephalosporin.. The Journal of Antibiotics. 52(7). 649–659. 9 indexed citations
10.
Matsumoto, Yoshimi, et al.. (1999). Antibacterial activity of cefixime against Salmonella typhi and applicability of Etest. Journal of Infection and Chemotherapy. 5(3). 176–179. 9 indexed citations
11.
Tawara, Shuichi, Kazuo Hatano, Yoshimi Wakai, et al.. (1999). In Vivo Antibacterial Activity of FK041, a New Orally Active Cephalosporin.. The Journal of Antibiotics. 52(7). 660–665. 9 indexed citations
12.
Barrett, David G., Akira Tanaka, Hiroshi Sasaki, et al.. (1997). Studies on β-lactam antibiotics. Synthesis and antibacterial activity of novel 1β-methylcarbapenems related to FR21818: 5-membered ring analogs. Bioorganic & Medicinal Chemistry Letters. 7(11). 1409–1414. 8 indexed citations
13.
MINE, YASUHIRO, Yuji Watanabe, Kazuo Hatano, et al.. (1993). Excellent activity of FK037, a novel parenteral broad-spectrum cephalosporin, against methicillin-resistant staphylococci.. The Journal of Antibiotics. 46(1). 99–119. 17 indexed citations
14.
Hatano, Kazuo, et al.. (1993). Animal pharmacokinetics of FK037, a novel parenteral broad-spectrum cephalosporin.. The Journal of Antibiotics. 46(1). 120–130. 19 indexed citations
15.
MINE, YASUHIRO, Yuji Watanabe, Kazuo Hatano, et al.. (1993). In vitro antibacterial activity of FK037, a novel parenteral broad-spectrum cephalosporin.. The Journal of Antibiotics. 46(1). 71–87. 23 indexed citations
16.
Tawara, Shuichi, Satoru Matsumoto, Yoshimi Matsumoto, Toshiaki Kamimura, & Sachiko Gotô. (1992). Structure-binding relationship and binding sites of cephalosporins in human serum albumin.. The Journal of Antibiotics. 45(8). 1346–1357. 18 indexed citations
17.
Tawara, Shuichi, Satoru Matsumoto, Toshiharu Hirose, et al.. (1989). In vitro antifungal synergism between pyrrolnitrin and clotrimazole.. Japanese Journal of Medical Mycology. 30(3). 202–210. 16 indexed citations
18.
MINE, YASUHIRO, Yoshiko Yokota, Yoshimi Wakai, et al.. (1988). In vivo antibacterial activity of FK482, a new orally active cephalosporin.. The Journal of Antibiotics. 41(12). 1888–1895. 7 indexed citations
19.
MINE, YASUHIRO, Yuji Watanabe, Shuichi Tawara, et al.. (1988). In vitro antibacterial activity of FK482, a new orally active cephalosporin.. The Journal of Antibiotics. 41(12). 1873–1887. 49 indexed citations
20.
MINE, YASUHIRO, Yuji Watanabe, Shuichi Tawara, et al.. (1983). IMMUNOACTIVE PEPTIDES, FK-156 AND FK-565. III. The Journal of Antibiotics. 36(8). 1059–1066. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Domingo Gargallo‐Viola Breakdown of academic impact, for papers by Andrew T. Nishimoto Breakdown of academic impact, for papers by Robert S. Gordee Breakdown of academic impact, for papers by Anna Karawajczyk Breakdown of academic impact, for papers by Haruaki Tomioka Breakdown of academic impact, for papers by Charles Gill Breakdown of academic impact, for papers by Keith Barrett‐Bee Breakdown of academic impact, for papers by Santiago Ramón‐García Breakdown of academic impact, for papers by Richard Hector Breakdown of academic impact, for papers by Khye Seng Goh
Rankless by CCL
2026